Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites

Reovirus is an oncolytic virus (OV), which acts by both direct tumor cell killing and priming of antitumor immunity. A major obstacle for effective oncolytic virotherapy is effective delivery of OV to tumor cells. Ovarian cancer is often confined to the peritoneal cavity and therefore i.p. delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Jennings, VA, Ilett, EJ, Scott, KJ, West, EJ, Vile, R, Pandha, H, Harrington, K, Young, A, Hall, GD, Coffey, M, Selby, P, Errington-Mais, F, Melcher, AA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321045/
https://www.ncbi.nlm.nih.gov/pubmed/23982804
http://dx.doi.org/10.1002/ijc.28450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321045/
https://www.ncbi.nlm.nih.gov/pubmed/23982804
http://dx.doi.org/10.1002/ijc.28450

Ejemplares similares